Dataset,Study Type,Total No. Participants Included,Mean (SD) No. Visits,Mean (SD) Months Followed,Mean (SD) ALSFRS-R Slope
PRO-ACT,Clinical Trial,2923,10 (4),11.86 (6.33),-1.09 (0.99)
CEFT,Clinical Trial,476,10 (5),19.09 (10.58),-1.20 (0.79)
AALS,Observational,456,5 (2),16.64 (8.78),-0.75 (0.65)
EMORY,Observational,399,6 (4),19.47 (14.74),-1.21 (1.20)
